 This study aims to evaluate the efficacy of augmented reality, AR, paste exposure therapy compared to in vivo exposure therapy, IVET and a waitlist control condition, WLC, in treating cockroach phobia. The study will employ a randomized controlled trial design and will assess participants' fear levels before and after treatment using the behavioral avoidance test. Additionally, secondary outcome measures such as attentional biases, beliefs about cockroaches, anxiety, depression, disgust propensity, sensitivity to disgust, state trait anxiety, clinical and severity scale, and satisfaction with treatment will also be assessed. This article was offered by Soledad Cuero, Jorge Grimaldos, Juana Bretón López, and others.